Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Merck
QuintilesIMS
Moodys
Cantor Fitzgerald
Argus Health
Deloitte
Teva
McKesson

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076525

« Back to Dashboard

NDA 076525 describes TERIL, which is a drug marketed by Taro Pharm and Taro and is included in two NDAs. It is available from three suppliers. Additional details are available on the TERIL profile page.

The generic ingredient in TERIL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
Summary for 076525
Tradename:TERIL
Applicant:Taro
Ingredient:carbamazepine
Patents:0
Therapeutic Class:Anticonvulsants
Bipolar Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 076525

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Sep 26, 2003TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
AstraZeneca
Chinese Patent Office
Cantor Fitzgerald
UBS
Fish and Richardson
Mallinckrodt
Covington
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.